ApoC-III plays a role in the pathogenesis of insulin-resistance and hypertriglyceridemia observed in lipodystrophy: ApoC-III levels are higher in lipodystrophy patients compared with overweight/obese controls independently of leptin deficiency and replacement [68]. The gene discussed is APOC3; the disease is lipodystrophy.